يعرض 1 - 10 نتائج من 70 نتيجة بحث عن '"Thomas, Klabunde"', وقت الاستعلام: 0.78s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion

    المؤلفون: Francesca Sacco, Sean J. Humphrey, Jürgen Cox, Marcel Mischnik, Anke Schulte, Thomas Klabunde, Matthias Schäfer, Matthias Mann

    المصدر: Nature Communications, Vol 7, Iss 1, Pp 1-13 (2016)

    مصطلحات موضوعية: Science

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2041-1723Test

    الوصول الحر: https://doaj.org/article/3361cb00241f44baab7bbae3776530c4Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide

    المؤلفون: Chiara Dalla Man, Michela Riz, Roberto Visentin, Claudio Cobelli, Thomas Klabunde, Michele Schiavon, Britta Göbel

    المصدر: Diabetes, Obesity & Metabolism

    مصطلحات موضوعية: Blood Glucose, Agonist, medicine.medical_specialty, medicine.drug_class, beta‐cell function, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Glucagon, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Receptors, Glucagon, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Insulin, insulin sensitivity, disposition index, liraglutide, glucagon‐like peptide‐1, beta-cell function, business.industry, Liraglutide, mixed meal tolerance test, Original Articles, medicine.disease, Glucagon-like peptide-1, dual agonist, Glucose, Postprandial, Diabetes Mellitus, Type 2, glucagon, glucagon-like peptide-1, Basal (medicine), oral minimal model, Original Article, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc18c21838d0011d5718b600bf3fdcd2Test
    https://doi.org/10.1111/dom.14394Test


    أضف إلى المفضلة
  3. 3
    In SilicoHead-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes

    المؤلفون: Chiara Dalla Man, Roberto Visentin, Jochen Sieber, Clemens Giegerich, Claudio Cobelli, Michele Schiavon, Thomas Klabunde

    المصدر: Diabetes Technology & Therapeutics

    مصطلحات موضوعية: Insulin degludec, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, In silico, 030209 endocrinology & metabolism, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Virtual trial, Pharmacokinetics, Internal medicine, Diabetes mellitus, medicine, Basal insulin, 030212 general & internal medicine, Mathematical modeling, Pharmacodynamics, Type 1 diabetes, Insulin glargine, business.industry, nutritional and metabolic diseases, Original Articles, medicine.disease, Medical Laboratory Technology, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d349ce4e7c9d5909703b43963be8003Test
    https://doi.org/10.1089/dia.2020.0027Test


    أضف إلى المفضلة
  4. 4
    Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes

    المؤلفون: Chiara Dalla Man, Claudio Cobelli, Roberto Visentin, Clemens Giegerich, Thomas Klabunde, Michele Schiavon

    المصدر: IEEE Transactions on Biomedical Engineering. 67:624-631

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Long acting insulin, medicine.medical_treatment, 0206 medical engineering, Biomedical Engineering, Insulin Glargine, 02 engineering and technology, Models, Biological, Text mining, Subcutaneous Absorption, Diabetes mellitus, Internal medicine, medicine, Humans, Insulin, Computer Simulation, Absorption (logic), Randomized Controlled Trials as Topic, Type 1 diabetes, Insulin glargine, business.industry, Chemistry, nutritional and metabolic diseases, Middle Aged, medicine.disease, 020601 biomedical engineering, Diabetes Mellitus, Type 1, Endocrinology, Female, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e568d20aef042abcc2d1d169cb11bf72Test
    https://doi.org/10.1109/tbme.2019.2919250Test


    أضف إلى المفضلة
  5. 5
    How high and long will the COVID-19 wave be? A data-driven approach to model and predict the COVID-19 epidemic and the required capacity for the German health system

    المؤلفون: Thomas Klabunde, Clemens Giegerich

    مصطلحات موضوعية: Coronavirus disease 2019 (COVID-19), business.industry, Social distance, Outbreak, language.human_language, law.invention, German, Geography, Transmission (mechanics), law, Intensive care, Health care, Pandemic, language, business, Demography

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227814b4a029e4d2aa1531fb62737a82Test


    أضف إلى المفضلة
  6. 6
    Dual glucagon-like peptide-1 receptor/glucagon receptor agonist SAR425899 improves beta-cell function in type 2 diabetes

    المؤلفون: Chiara Dalla Man, Roberto Visentin, Thomas Klabunde, Michele Schiavon, Claudio Cobelli, Michela Riz, Britta Göbel

    مصطلحات موضوعية: Agonist, Blood Glucose, medicine.medical_specialty, medicine.drug_class, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Placebo, Glucagon, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, medicine, Receptors, Glucagon, Humans, Hypoglycemic Agents, Insulin, insulin sensitivity, disposition index, C-Peptide, business.industry, beta-cell function, dual agonist, glucagon, glucagon-like peptide 1, oral minimal model, Area under the curve, medicine.disease, Glucagon-like peptide-1, Postprandial, Diabetes Mellitus, Type 2, business, Glucagon receptor

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::529a67e7363ddbb1bdb42653537f682dTest
    http://hdl.handle.net/11577/3332939Test


    أضف إلى المفضلة
  7. 7
    Author response for 'Dual GLP-1R/GCGR Agonist SAR425899 Improves Beta-cell Function in Type 2 Diabetes'

    المؤلفون: Michela Riz, Claudio Cobelli, Roberto Visentin, Thomas Klabunde, Michele Schiavon, Chiara Dalla Man, Britta Göbel

    مصطلحات موضوعية: Agonist, business.industry, medicine.drug_class, Medicine, Beta-cell Function, Type 2 diabetes, DUAL (cognitive architecture), Pharmacology, business, medicine.disease

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0884c89f20348fb541dc7c10747615Test
    https://doi.org/10.1111/dom.13939/v2/response1Test


    أضف إلى المفضلة
  8. 8
    مؤتمر
    IN SILICO HEAD-TO-HEAD COMPARISON OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC IN TYPE 1 DIABETES

    المؤلفون: Roberto Visentin, Michele Schiavon, Clemens Giegerich, Jochen Sieber, Chiara Dalla Man, Claudio Cobelli, Thomas Klabunde

    المساهمون: Visentin, Roberto, Schiavon, Michele, Giegerich, Clemen, Sieber, Jochen, DALLA MAN, Chiara, Cobelli, Claudio, Klabunde, Thomas

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000425015800052; ispartofbook:Abstracts from ATTD 2018 11th International Conference on Advanced Technologies & Treatments for Diabetes; ATTD 2018 - 11th International Conference on Advanced Technologies & Treatments for Diabetes; volume:20; firstpage:A18; lastpage:A18; numberofpages:1; journal:DIABETES TECHNOLOGY & THERAPEUTICS; http://hdl.handle.net/11577/3259628Test

    الإتاحة: https://doi.org/10.1089/dia.2018.2525.abstractsTest
    http://hdl.handle.net/11577/3259628Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay

    المؤلفون: Alexandre Brkovic, Almut Hattenberger, Evi Kostenis, Thomas Klabunde, Stefanie Flohr, Michael Kurz, AND Steve Bourgault, Alain Fournier

    المساهمون: The Pennsylvania State University CiteSeerX Archives

    المصدر: http://jpet.aspetjournals.org/content/jpet/306/3/1200.full.pdfTest.

    وصف الملف: application/pdf

    العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1078.5696Test; http://jpet.aspetjournals.org/content/jpet/306/3/1200.full.pdfTest

    الإتاحة: http://jpet.aspetjournals.org/content/jpet/306/3/1200.full.pdfTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies

    المؤلفون: Roberto Visentin, Claudio Cobelli, Chiara Dalla Man, Thomas Klabunde, Clemens Giegerich, Michele Schiavon

    المصدر: IEEE transactions on bio-medical engineering. 66(10)

    مصطلحات موضوعية: Blood Glucose, In silico, medicine.medical_treatment, 0206 medical engineering, Biomedical Engineering, Insulin Glargine, 02 engineering and technology, Drug Administration Schedule, Injections, Pharmacokinetics, Statistical significance, medicine, Clinical endpoint, Humans, Hypoglycemic Agents, Basal insulin, Computer Simulation, Dosing, Simulation, Type 1 diabetes, Insulin, Modeling, nutritional and metabolic diseases, Glucose variability, In silico clinical trial, medicine.disease, 020601 biomedical engineering, Pharmacokinetics (PKs), Clinical trial, Insulin, Long-Acting, Pharmacodynamics, Diabetes Mellitus, Type 1

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae9ee4dc06080b55435efa022e730943Test
    https://pubmed.ncbi.nlm.nih.gov/30735983Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث